IntroductionVaccination coverage levels of the National Immunisation Program (PNI) in Brazil ranges from 80% to 95%, suggesting that parental acceptance of these vaccines is high. In 2014, HPV vaccine was introduced in the PNI. We conducted a survey to estimate parental acceptance of HPV vaccine and its determinants.MethodsThis was a random digit calling telephone survey performed in seven large cities from all five regions in Brazil. Eligible parents had to have one or more child less than 18 years old. We selected at least 100 subjects in each city. A standardised questionnaire was used to collect sociodemographic informationa and data on knowledge, attitudes and practices related to HPV vaccine, cervical cancer and HPV. Trained personnel conducted the interviews that lasted on average 20 min.ResultsOverall 826 parents were included in the survey (73% response rate). Parental acceptance for vaccinating against HPV was similarly high for female or male children, 92.8% and 91.7%, respectively. It did not change significantly among the cities studied (range 86.3%–95.5%). Parents’s main reasons to give the HPV vaccine to their children were: “Vaccines are good/important”(85.6%), “Prevents cervical cancer”(6.6%), and “Vaccine is in the PNI”(3.3%). Only 0.7% reported “Prevents genital warts”. Among parents with girls eligible for HPV vaccination (10–14 years old) under the PNI (n=291), 71.4% had their daughters vaccinated.ConclusionParental acceptance of HPV vaccine is high (92%%), but a lower percentage results in actual vaccination. Moreover, the main reason to vaccinate is based on a vague assumption (“vaccines are good/important”). Only few parents reported that HPV vaccination prevents cervical cancer. Parents whose vaccine acceptance is ill founded and based on poor knowledge are more vulnerable to change their mind when challenged by stress related mass reactions to HPV vaccine reported by the media or when facing false arguments against vaccination by anti-vax reports.
Objectives The RAIDs consortium (www.raids-fp7.eu), conducted a prospective cervical cancer study, [BioRAIDs (NCT02428842)]. The clinical and biological dataset included 419 patients from 18 centers in 7 EU countries (Ngo et al, 2015; Samuels et al, 2016 and Scholl et al, in press). Objec-10.1136/ijgc-2019-IGCS.206 Objectives To assess the effectiveness of a new training programme with a shorter duration of training for cervical cancer prevention among professional Medical Practitioners (PMPs). Methods The new training method consisted of video based tutorials, lectures and hands on training for 2 weeks. PMPs
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.